These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 22617734

  • 1. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
    Sorensen SV, Goh JW, Pan F, Chen C, Yardley D, Martín M, Knopf K, Benedict A, Giorgetti C, Iyer S.
    Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
    [Abstract] [Full Text] [Related]

  • 2. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K, Danchenko N, Gondek K, Schwartz B, Thompson D.
    Urol Oncol; 2007 Jan; 25(5):368-75. PubMed ID: 17826652
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM, Shim B, Goodman S, Amonkar MM.
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [Abstract] [Full Text] [Related]

  • 4. Cost of illness associated with metastatic breast cancer.
    Rao S, Kubisiak J, Gilden D.
    Breast Cancer Res Treat; 2004 Jan; 83(1):25-32. PubMed ID: 14997052
    [Abstract] [Full Text] [Related]

  • 5. The economic burden of metastatic breast cancer: a U.S. managed care perspective.
    Montero AJ, Eapen S, Gorin B, Adler P.
    Breast Cancer Res Treat; 2012 Jul; 134(2):815-22. PubMed ID: 22684273
    [Abstract] [Full Text] [Related]

  • 6. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M.
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [Abstract] [Full Text] [Related]

  • 7. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
    Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS.
    J Clin Oncol; 2009 Apr 20; 27(12):2007-14. PubMed ID: 19289624
    [Abstract] [Full Text] [Related]

  • 8. Cost of care for elderly cancer patients in the United States.
    Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, Brown ML.
    J Natl Cancer Inst; 2008 May 07; 100(9):630-41. PubMed ID: 18445825
    [Abstract] [Full Text] [Related]

  • 9. The burden of illness associated with hepatocellular carcinoma in the United States.
    Lang K, Danchenko N, Gondek K, Shah S, Thompson D.
    J Hepatol; 2009 Jan 07; 50(1):89-99. PubMed ID: 18977551
    [Abstract] [Full Text] [Related]

  • 10. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L, Hakama M.
    Acta Oncol; 1997 Jan 07; 36 Suppl 9():1-60. PubMed ID: 9143316
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
    Baser O, Wei W, Henk HJ, Teitelbaum A, Xie L.
    Curr Med Res Opin; 2012 Mar 07; 28(3):419-28. PubMed ID: 22364568
    [Abstract] [Full Text] [Related]

  • 13. Assessing the economic burden of breast cancer in a US managed care population.
    Barron JJ, Quimbo R, Nikam PT, Amonkar MM.
    Breast Cancer Res Treat; 2008 May 07; 109(2):367-77. PubMed ID: 17674201
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P, Whiteford H, Vos T, Bertram M.
    J Ment Health Policy Econ; 2012 Mar 07; 15(1):25-32. PubMed ID: 22611090
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The burden of prenatal exposure to alcohol: revised measurement of cost.
    Stade B, Ali A, Bennett D, Campbell D, Johnston M, Lens C, Tran S, Koren G.
    Can J Clin Pharmacol; 2009 Mar 07; 16(1):e91-102. PubMed ID: 19168935
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD.
    Neurology; 2008 Jul 01; 71(1):21-7. PubMed ID: 18591502
    [Abstract] [Full Text] [Related]

  • 20. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ, Scuffham PA, McCollam PL, Newby DE.
    Curr Med Res Opin; 2007 Mar 01; 23(3):495-503. PubMed ID: 17355731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.